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OBJECTIVES We sought to analyze whether a microcirculatory dysfunction might be associated with
isolated ventricular noncompaction (IVNC).
BACKGROUND In IVNC, which is a cardiomyopathy thus far “unclassified” by the World Health
Organization, heart failure and sudden cardiac death are common findings, but the
pathophysiologic mechanisms are unknown.
METHODS In 12 patients with IVNC and 14 control subjects, quantitative evaluation of regional
myocardial perfusion (myocardial blood flow [MBF]) and coronary flow reserve (CFR,
hyperemic/baseline MBF) was performed using positron emission tomography and 13N-
ammonia. The left ventricular myocardium was divided into nine segments, and the
two-dimensional echocardiogram in each patient with IVNC was compared with CFR in
each segment. Noncompaction was defined as a two-layered structure with excessive
trabeculation.
RESULTS The CFR in control subjects averaged 4.2  0.9, providing a cut-off value 2.5, but it was
2.1  0.8 in patients with IVNC. A perfusion scan defect was found in 14 of 24 segments
with noncompaction, although no defect was found in 76 of 84 normal segments (overall
agreement 83%, p  0.0001 by the chi-square test). In 16 of 21 segments with noncompac-
tion, a decreased CFR was found; but a decreased CFR was also found in 36 of 60 segments
without noncompaction (p  NS). In 45 of the 57 segments with wall motion abnormalities,
CFR was decreased, but it was preserved in 17 of the 24 segments with normal wall motion
(agreement 77%, p  0.0001).
CONCLUSIONS In patients with IVNC, a decreased CFR is not confined to noncompacted segments, but
extends to most segments with wall motion abnormalities. Thus, coronary microcirculatory
dysfunction is associated with IVNC. (J Am Coll Cardiol 2002;39:450–4) © 2002 by the
American College of Cardiology
According to the present World Health Organization
(WHO) definition, cardiomyopathies are now classified by
the dominant pathophysiology or, if possible, by etiologic/
pathogenetic factors (1). As the etiology of isolated ventric-
ular noncompaction (IVNC) is not fully elucidated, IVNC
has been unspecifically assigned to a heterogeneous group of
“unclassified cardiomyopathies.” The disease is thought to
be a morphogenetic abnormality involving an arrest of
compaction of the loose myocardial meshwork during fetal
ontogenesis (2,3), thus, present at birth in all patients (4,5).
Heart failure, arrhythmia, embolism and sudden cardiac
death are common clinical manifestations of IVNC (6,7).
Chest pain was found in 26% of patients with IVNC (7).
Echocardiographic characteristics of IVNC have been val-
idated at autopsy and include, in the absence of any
coexisting lesion, segmental thickening of the left ventric-
ular (LV) myocardial wall consisting of two layers (Fig. 1,
left): a thin, compacted epicardial layer and an extremely
thick endocardial layer with prominent trabeculations and
deep recesses (8). The pathophysiology of myocardial per-
fusion may play a crucial role in IVNC, with ischemia
possibly resulting from underlying abnormalities of the
coronary microcirculation, as suggested by postmortem
analyses of IVNC hearts with ischemic subendocardial
lesions (7,8).
We hypothesized that these findings may originate in, or
at least be partly due to, a functional impairment of the
coronary microcirculation. The purpose of the present
report was to study whether IVNC is associated with a
microcirculatory dysfunction.
METHODS
Study group. A total of 12 patients, derived from a
previously reported series of 34 patients with IVNC (7), was
studied (mean age 49  18 years). The diagnostic criteria
for IVNC have been validated at autopsy (8). Briefly, IVNC
is characterized by a two-layer structure with a compacted,
thin epicardial band and a much thicker, noncompacted
endocardial layer of trabecular meshwork with deep endo-
myocardial spaces and color Doppler evidence of deep
perfused intertrabecular recesses. A maximal end-systolic
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ratio of noncompacted to compacted layers of 2 is diag-
nostic. The patients were chosen consecutively on their
scheduled routine visit to the outpatient clinic. Seven of the
reported patients had shortness of breath (4 patients in New
York Heart Association functional class II and 3 patients in
class III) and two had chest pain. Left bundle branch block
was present in three patients and repolarization abnormal-
ities in four patients. Cardiovascular risk factors were
present in three patients. Four patients, including the two
with chest pain, had undergone coronary angiography,
which revealed normal coronary arteries.
Fourteen volunteers without cardiovascular disease served
as control subjects (mean age 34  15 years; p  0.01 vs.
patients with IVNC). None of the control subjects had a
history of cardiovascular disease or risk factors. Entrance
criteria included a normal heart rate, normal blood pressure,
a normal rest electrocardiogram and a low clinical probabil-
ity of coronary artery disease (9).
Positron emission tomography. Positron emission tomo-
graphic (PET) studies were performed with a GE Advance
PET scanner (GE Medical Systems, Milwaukee, Wiscon-
sin; axial field of view 35  4.25 mm). All volunteers were
injected with 700 to 900 MBq of 13N-ammonia into a
peripheral vein by the bolus technique, while acquisition of
the serial transaxial tomographic images of the heart was
started (12  10-s, 4  30-s, 1  60-s and 2  300-s
frames). After 20-min acquisition, a 20-min transmission
scan for photon attenuation correction was performed using
external 68Ge sources. Myocardial blood flow (MBF) was
assessed at rest and during standard pharmacologic stress
(i.e., dipyridamole in control subjects and adenosine in
patients with IVNC). Both dipyridamole and adenosine
have been shown to induce equivalent hyperemia at the
applied intravenous dose and rate (10).
Data analysis. The heart was divided into nine segments:
the whole apex was one segment (apical segment), and at
the base and mid-ventricular levels, the LV was divided into
four segments each—septal, anterior, lateral and inferior. A
region of interest (ROI) was placed in each segment, as well
as into the LV blood pool.
Myocardial blood flow was estimated by model fitting of
the blood pool and myocardial time–activity curves (11).
Correction for partial volume and spillover (both accounting
for the resolution distortion) was performed using the
method developed (12) and validated by Hutchins et al.
(13). Briefly, the ROI was chosen to contain only myocar-
dial tissue and blood; thus, the relationship between the
measured PET counts in a region (CPET) and the true
counts in myocardium (Cm) and arterial blood (Ca) was
modeled as follows: CPET(t)  FaCa(t)  (1  Fa)Cm(t),
where Fa is the fractional contribution of the blood pool to
measured PET counts in a region and is dependent on the
placement of the region, the resolution of the camera and
the movement of the myocardium. Because the contribution
of the myocardium to total regional counts decreases with
an increasing blood pool fraction, Cm is multiplied by (1 
Fa). Fa was estimated, together with the other kinetic tissue
variables, by using least-squares fitting. Determination of
the fraction of the ROI volume occupied by blood (Fa) by
either measurement or variable estimation procedures elim-
inates the resolution distortion in the kinetic data. This
strategy of spillover correction seems to be the most appro-
Abbreviations and Acronyms
CFR  coronary flow reserve
IVNC  isolated ventricular noncompaction
LV  left ventricular or ventricle
MBF  myocardial blood flow
PET  positron emission tomography
ROI  region of interest
WHO  World Health Organization
Figure 1. Mid-ventricular short-axis view of an echocardiographic recording (left) showing septal, inferior and lateral hypertrabeculation and a two-layered
structure of the left ventricular myocardium, indicative of noncompaction. The corresponding nongated 13N-ammonia scan (right) shows lateral and inferior
irregularities. PET  positron emission tomography.
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priate in light of the depth of the sinusoids in IVNC.
Coronary flow reserve (CFR) was calculated as the ratio of
hyperemic to rest MBF values. The images of the last 300-s
frame were used to grade each segment as a normal
perfusion scan or a defect for rest and stress.
Echocardiography. Two-dimensional and Doppler echo-
cardiographic studies were performed in patients with
IVNC, according to the recommendations of the American
Society of Echocardiography (14–16). The LV ejection
fraction was calculated using the biplane area–length
method (17). The LV wall was divided into nine segments
to describe the location of the noncompacted segments: the
whole apex was one segment (apical segment) and at the
base and mid-ventricular levels, the LV was divided into
four segments each—septal, anterior, lateral and inferior.
Systolic function was graded as normal or abnormal (i.e.,
hypokinetic, akinetic or dyskinetic segment). The echocar-
diographic data were scored by an operator who had no
knowledge of the PET data and reported in Table 1. The
study protocol was approved by the institutional Research
Ethics Committee.
Statistical analysis. Statistical comparisons of hemody-
namic data, MBF and CFR were carried out by one-way
analysis of variance for repeated measures. When the
analysis was significant, the Sheffe´ F test was applied. Data
are reported as the mean value  SD. The chi-square test
was used for categorical analysis of nominal data.
RESULTS
All procedures were well tolerated, except in one IVNC
patient in whom adenosine stress testing had to be discon-
tinued because of common side effects, such as dyspnea and
chest pain.
Hemodynamic data. Heart rate, systolic and diastolic
blood pressure and the rate–pressure product were compa-
rable in both groups. Using dipyridamole and adenosine
stress, the heart rate increased significantly in both groups,
except in one patient with IVNC (nonresponder, as de-
scribed in the following text).
Myocardial blood flow and CFR. Hyperemic MBF could
not be analyzed in three patients with IVNC (one nonre-
sponder to adenosine, one who had a technical problem and
one in whom adenosine was discontinued due to side
effects); the remaining nine patients with IVNC (mean age
45  17) underwent quantitative analysis. Global MBF at
baseline was similar between control subjects (0.78  0.25
ml/g per min) and patients with IVNC (0.86  0.30 ml/g
per min; p  NS). Dipyridamole induced a significant
increase in MBF in control subjects (3.18  1.23 ml/g per
min; p  0.0001 vs. baseline), whereas the hyperemic
response was significantly reduced in patients with IVNC
(1.72  0.75 ml/g per min, p  0.0005 vs. patients with
IVNC). Global CFR was 4.21  0.86 for control subjects,
resulting in a cutoff value (mean 2 SD) of 2.49 for
reduced CFR. In patients with IVNC, CFR was signifi-
cantly reduced, as compared with that in control subjects
(2.13  0.83; p  0.001 vs. control subjects). In patients
with IVNC, all segments were categorized as having a
normal (2.5) or decreased (2.5) CFR.
Echocardiography and PET. Trabeculation was most
commonly found in the apical and mid-ventricular lateral
wall, followed by the mid-ventricular inferior wall, as
previously reported (7,8). All noncompacted segments, but
also 35 of 60 normally compacted segments, were hypoki-
netic. In patients with IVNC, a fixed perfusion scan defect
was found in 14 of 24 segments with noncompaction,
whereas normal perfusion was found in 76 of 84 segments
without trabeculation (overall agreement 83%, p  0.0001
by the chi-square test). In 16 of 21 segments with noncom-
paction, a decreased CFR was found, but a decreased CFR
was also found in 36 of 60 segments without trabeculation
(p  NS).
In 45 of the 57 segments with wall motion abnormalities,
CFR was decreased, whereas CFR was normal in 17 of the
24 segments with normal wall motion (agreement 77%, p
0.0001) (Fig. 2). For the echocardiographic findings in
patients with IVNC, see Table 1.
DISCUSSION
Assessment of microcirculatory dysfunction in patients
with IVNC. Isolated ventricular noncompaction is a rare
and unique congenital disorder categorized as an unclassi-
fied cardiomyopathy by WHO in 1995. Despite an increas-
ing interest in this congenital anomaly in the past decade, as
reflected by several recent reports (4–7,18–21), following
the initial publications (2,3), the pathophysiologic mecha-
nisms of LV dysfunction in patients with IVNC remains
unclear. To the best of our knowledge, this is the first
systematic report to provide evidence for an underlying
microcirculatory dysfunction in IVNC. A decreased rest and
hyperemic MBF has previously been found in a case report
of five children with IVNC, but without statistical analysis,
as MBF was only successfully quantified using PET in three
patients (22). Our results in adults with IVNC demonstrate
a preservation of MBF at rest, but a significantly impaired
increase in MBF during maximal hyperemia with adeno-
Table 1. Echocardiographic Data in Patients With Isolated
Ventricular Noncompaction
LVEDD (mm) 56  20 (normal: 60)
Fractional shortening (%) 25  8 (normal: 29–46)
Ejection fraction (%) 42  18 (normal: 50)
Left atrial size (mm) 42  8 (normal: 15–40)
Thickness of basal septum (mm) 11  4 (normal: 6–12)






*Diastolic function was not assessed in one patient. Data are presented as the mean
value  SD or number (n) of patients.
LVEDD  left ventricular end-diastolic diameter.
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sine, resulting in a decreased CFR. We have used a strategy
for placement of the myocardial ROI in the PET scan,
which proposes the inclusion of myocardial tissue as well as
the LV blood pool (12,13). This seems appropriate for ana-
lyzing patients with IVNC with deep recesses, because any
such model needs to correct for an admixture of perfused
muscle with vasodilation and blood in the recesses without
vasodilation. Thus, the observed lack of a flow increase in
IVNC is unlikely to simply reflect a partial volume effect.
Relationship between microcirculatory dysfunction and
wall motion abnormalities. Coronary flow reserve, defined
as the ratio of near maximal to basal myocardial flow, has
been proposed as an indirect variable to evaluate the
function of the coronary circulation (23). It is an integrated
measure of coronary flow through both the large epicardial
coronary arteries and the microcirculation. A decrease in
CFR can be due to narrowing of epicardial coronary arteries
(24), which is, however, unlikely in our group of patients
with IVNC, as previously documented (3,6,7), or to a
microvascular dysfunction (25). A similar microcirculatory
dysfunction has been reported in other cardiomyopathies. In
hypertrophic obstructive cardiomyopathy, an impaired cor-
onary vasodilator reserve, as assessed with PET, has been
found in both hypertrophied and nonhypertrophied regions
of the LV, suggesting that ischemia may result from
abnormalities of the coronary microcirculation (26). Simi-
larly, in IVNC, the microcirculatory dysfunction was not
confined to the trabeculated segments, but was found to
extend to many nontrabeculated segments. This indicates
that the hypertrophy, per se, is unlikely to account for the
decreased CFR, as the latter was also found in nonhyper-
trophied segments. In most of these segments, a wall
motion abnormality was found. In contrast, however, in
most of the segments without a wall motion abnormality, a
normal CFR was preserved. This provides evidence that the
microcirculatory dysfunction may be associated with wall
motion abnormalities and, thus, with heart failure in pa-
tients with IVNC. The causal relationship between micro-
circulatory and contractility dysfunction in IVNC cannot be
identified with certainty by our observational study. How-
ever, it appears reasonable to assume that the microvascular
dysfunction might be responsible for the contractile impair-
ment, particularly during high-demand situations, explain-
ing the subendocardial scar, as found in histologic prepara-
tions of patients with IVNC (8), and reflected by fixed
ammonia defects in our study, despite no evidence of a
previous myocardial infarction. Recently, impaired aerobic
fatty acid metabolism has been found in noncompacted
segments, supporting the hypothesis that myocardial failure
in IVNC may be a result of ischemia (27).
Study limitations. Patients with IVNC were slightly older
than control subjects. This difference may potentially ham-
per the comparability of the two groups’ flow reserve, as the
maximal hyperemic response decreases significantly after the
age of 70 years, and the flow reserve has been shown to
decrease after the age of 60 years (28), mainly due to an
increase in basal flow (29). However, only two of our
patients were 60 years, and the baseline flow was not
increased in patients with IVNC as compared with control
subjects. Thus, the significant decrease in CFR in patients
with IVNC cannot be explained by the slight age difference.
Although equipotent doses of the two stressors, adeno-
sine and dipyridamole (10), have been used, resulting in the
same hyperemic MBF values on PET (30), a slightly stronger
hyperemic effect of adenosine over dipyridamole has recently
been reported (31). Therefore, adenosine would overestimate
CFR. As this was used in patients with IVNC who had
decreased CFR values, this would even strengthen our results.
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Figure 2. Comparison between echocardiography and positron emission tomography in patients with isolated ventricular noncompaction. The
microcirculatory dysfunction is not confined to noncompacted segments (right and middle), but extends to most myocardial segments with wall motion
abnormalities (left). Perfusion defects were assessed in 12 patients (108 segments); quantification was successful in only nine patients (81 segments). CFR
coronary flow reserve.
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